TELA
TELA Bio, Inc.
TELA's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over TELA overall, supported by lower modeled downside and stronger valuation.
TELA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Unavailable |
TELA's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
TELA PE Valuation
TELA has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
TELA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TELA's losses to shrink, with revenue holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
TELA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.74 | +$0.09 |
| Q2 2026 | -$0.77 | +$0.29 |
| Q1 2026 | -$0.79 | +$0.56 |
| Q4 2025 | -$0.83 | +$0.50 |
| Q3 2025 | -$0.83 | +$0.83 |
| Q2 2025 | -$1.06 | +$0.63 |
| Q1 2025 | -$1.35 | +$0.29 |
| Q4 2024 | -$1.33 | +$0.71 |
TELA is still losing money, but far less than before: $0.74 per share over the past year, against $2.87 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over TELA on earnings quality, reporting a profit while its opponent remains loss making.
TELA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -8.4% |
| Q2 2026 | $19.3M | -4.5% |
| Q1 2026 | $19.1M | +2.9% |
| Q4 2025 | $20.9M | +18% |
| Q3 2025 | $20.7M | +9.1% |
| Q2 2025 | $20.2M | +26% |
| Q1 2025 | $18.5M | +12% |
| Q4 2024 | $17.6M | +3.8% |
TELA's revenue has held roughly level: $19M last quarter, down 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -38% | -1.9 points |
| Q2 2026 | -48% | -3.2 points |
| Q1 2026 | -55% | +1.3 points |
| Q4 2025 | -32% | +16 points |
| Q3 2025 | -37% | +13 points |
| Q2 2025 | -45% | +27 points |
| Q1 2025 | -57% | -28 points |
| Q4 2024 | -47% | +25 points |
TELA's operating margin was −38% last quarter, down 1.9 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over TELA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over TELA on profitability, with a higher operating margin.
TELA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.7M | -$2.8M |
| Q2 2026 | -$9.4M | -$1.4M |
| Q1 2026 | -$11.3M | -$1.5M |
| Q4 2025 | -$5M | +$2.8M |
| Q3 2025 | -$5.9M | +$3.2M |
| Q2 2025 | -$8M | +$3M |
| Q1 2025 | -$9.8M | +$4.9M |
| Q4 2024 | -$7.8M | +$3.5M |
TELA has burned cash in almost every quarter: −$34M over the past year, against −$32M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over TELA on cash generation, producing positive trailing cash flow while its opponent burns cash.
TELA Net Leverage
TELA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
TELA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.7 | Neutral |
| Stochastic | 25.3 | Neutral |
TELA's weekly RSI is 48 (neutral) and its Stochastic is 25 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
TELA PE vs Healthcare Sector
TELA has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
TELA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.99 | 13% below |
| 20 week MA | $0.88 | 2.3% below |
| 50 week MA | $0.88 | 2.3% below |
| 100 week MA | $1.34 | 36% below |
| 200 week MA | $4.07 | 79% below |
TELA is in a downtrend: it's below all five of its weekly moving averages, and 79% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over TELA on trend strength, trading above more of its moving averages.
TELA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.7 | $16.0 | +26% |
| 2021 | $16.0 | $12.5 | -22% |
| 2022 | $12.5 | $11.3 | -10% |
| 2023 | $11.3 | $6.62 | -41% |
| 2024 | $6.62 | $2.91 | -56% |
| 2025 | $2.91 | $1.14 | -61% |
| 2026 YTD | $1.14 | $0.86 | -25% |
TELA has finished five years in a row lower, and it's down 25% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over TELA on returns for 2026, with the stronger performance.